Loading...
C3M
The Centre Méditerranéen de Médecine Moléculaire was set up in 2008 as a result of the desire to bring together teams who were all keen to work more closely with the clinic and to improve their interactions. The Centre's location within the Hôpital de l'Archet facilitates the transfer from the clinic to fundamental research and vice versa. The C3M comprises 13 teams (website https://www.c3m-nice.fr/) with a total of 175 staff, divided into 3 research areas: - Proliferation, cell death, differentiation and cancer - Metabolic diseases - Infection and inflammatory responses. C3M has a major cell imaging and cytometry platform with IBISA accreditation.
Last Deposits
Documents in Full Text
411
Notices
429
Statistics by Discipline
Keywords
Metabolism
Monocytes
Aged
Apoptose
Metformin
Leishmania
Binge eating disorder
Genomics
Inflammasome
Angiogenesis
IRE1α
Bacteremia
Métabolisme
Chronic hepatitis C
Non-alcoholic fatty liver disease
Artificial intelligence
Chronic myeloid leukemia
Genetic
Cell Proliferation
B-Lymphocytes
NAFLD
Adipose tissue
Macrophages
Quality of Life
Extracellular matrix
Liver fibrosis
ER stress
Cirrhosis
Bariatric surgery
Stress
Glycolysis
Cells
Cell death
Cultured
Autophagy
Prostate cancer
Actin cytoskeleton
Atherosclerosis
France
Cell biology
Diagnosis
NASH
Quality
Humans
COVID-19
UPR
Prognosis
Antiviral Agents
Genetic Vectors
MITF
Cell Line
Mitochondria
Animals
Lentivirus
Cancer
Immunotherapy
Membrane Glycoproteins
Innate immunity
Epidemiology
Liver Cirrhosis
Carcinoma
Aging
HEK293 Cells
Diabetes
Rac1
DDR
Chronic
Cell proliferation
Apoptosis
Fibrosis
Male
Mechanotransduction
Mice
Steatosis
Hypoxia
Glutamine
Liver
Female
Mélanome
Foie
Hepatitis C
Macrophage
Resistance
AML
Clear cell Renal Cell Carcinoma
Transduction
Obesity
Cohort Studies
Melanoma
Adipocytes
Breast cancer
Immunometabolism
Adult
Leukemia
MAFLD
Inflammation
Lymphocyte Activation
Middle Aged
Targeted therapies
Hepatocellular carcinoma